Picture of 23andMe Holding Co. logo

ME — 23andMe Holding Co. Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Momentum

Relative Strength (%)
1m-7.37%
3m-18.18%
6m-54.79%
1yr-78.34%
Volume Change (%)
10d/3m+38.43%
Price vs... (%)
52w High-81.65%
50d MA-12.63%
200d MA-58.31%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-25.45%
Return on Equity-37.58%
Operating Margin-93.48%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of 23andMe Holding Co. EPS forecast chart

Profile Summary

23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company's segments include Consumer & Research Services and Therapeutics. The Consumer & Research Services segment comprises its Personal Genome Service (PGS), telehealth business, and research services. Its PGS service provides customers with a suite of genetic reports, including information on customers genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. Its telehealth platform provides patients with access to medical consultation and treatment. Through its research services, it uses its database of genetic and phenotypic information to identify targets for drug development. The Therapeutics segment focuses on the use of genetic insights from its database of genetic and phenotypic information to develop therapies to improve patients lives.

Directors

    Last Annual
    March 31st, 2022
    Last Interim
    March 31st, 2022
    Incorporated
    June 16th, 2021
    Public Since
    March 3rd, 2012
    No. of Shareholders
    359
    No. of Employees
    728
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Global Select Market
    Shares in Issue
    449,173,121

    ME Share Price Performance

    Upcoming Events for ME

    Similar to ME

    Picture of 1life Healthcare logo

    1life Healthcare

    us flag iconNASDAQ Global Select Market

    Picture of Acadia Healthcare logo

    Acadia Healthcare

    us flag iconNASDAQ Global Select Market

    Picture of Accolade logo

    Accolade

    us flag iconNASDAQ Global Select Market

    Picture of Addus HomeCare logo

    Addus HomeCare

    us flag iconNASDAQ Global Select Market

    Picture of Alignment Healthcare logo

    Alignment Healthcare

    us flag iconNASDAQ Global Select Market

    FAQ

    Or unlock with your email

    Or unlock with your email